Diabetes care
Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis.
Kagan E Karakus, Halis K Akturk, Davida Kruger, Andrew Ahmann, Anuj Bharvaga, Christine R Langel, Courtney A Ackeifi, Jonathan Rosen, Laura Pyle, Janet K Snell-Bergeon, Viral N Shah
Published: 202510.2337/dc25-2249
Abstract
OBJECTIVE: In this post hoc analysis, we used the data from the Adjunct Semaglutide Treatment in Type 1 Diabetes (ADJUST-T1D) trial, a double-blind, multicenter, randomized, placebo-controlled trial of semaglutide 1 mg/week in adults with type 1 diab…
Preview only. Read the full abstract at the source